US Big Pharma Lobbies Trump to Tariff Australian Drug Imports
The move is aimed at securing leverage over Australia’s Pharmaceutical Benefits Scheme. Health Minister Mark Butler has sought to reassure Australians that there won’t be any changes to the nation’s $18 billion Pharmaceutical Benefits Scheme (PBS) following calls for punitive tariffs on Australian medications imported by the United States. U.S. pharmaceutical companies, via the Pharmaceutical